ROFLUMILAST
NDC 59651-801, ROFLUMILAST, tablet, from Aurobindo Pharma Limited.
- Product NDC
- 59651-801
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213298
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-801 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROFLUMILAST250 ug/1
Pharmacologic classes
Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-801-20 | 59651080120 | 1 BLISTER PACK in 1 CARTON (59651-801-20) / 20 TABLET in 1 BLISTER PACK |
| 59651-801-28 | 59651080128 | 1 BLISTER PACK in 1 CARTON (59651-801-28) / 28 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7cb11d48-6bb9-437b-bc7f-382050a2d3e6NADAC price for package 59651080120
GET /v1/drugs/nadac/59651080120NADAC price for package 59651080128
GET /v1/drugs/nadac/59651080128
Use it
Look up 59651-801 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-801 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-801. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.